Skip to main content
. 2022 Dec 20;11(1):5. doi: 10.3390/vaccines11010005

Table 1.

Clinical Parameters at Peak Illness for COVID-19 Episodes.

Parameter: Primary Infection
(March) *
Reinfection
(July) *
Vital Signs:
Temperature (°C) 38.4 37.0
Heart Rate (/min) 101 86
Blood pressure (mmHg) 156/96 143/93
Respiratory Rate (/min) 20 19
SpO2 (%) on supplemental O2 rate 93% on 6 L/min 94–97% on 3 L/min
BMI (kg/m2) 18.7 20.4
Laboratory:
Total white blood count (cells/µL) 16,200 6700
Absolute neutrophil count (cells/µL) 12,960 2010
Absolute lymphocyte count (cells/µL) 1600 600
Hematocrit (%) 39.6% 42.8%
Platelet count (cells/µL) 290,000 240,000
D-dimer (≤0.49 µg/mL) ** N/A 0.47
Creatinine (mg/dL) 1.01 1.07
Procalcitonin (≤0.25 ng/mL) ** 0.15 0.08
C-reactive protein (≤5 mg/L) ** N/A <3.0
SARS-CoV-2 rt-PCR CT (target 1) † 22.8 (E) 43.3 (E)
SARS-CoV-2 rt-PCR CT (target 2) † 26.5 (RdRp) 39.6 (N2)

* Peak day of illness for each COVID-19 episode is given. For primary infection, peak illness occurred in the 1st hospitalization (March) on hospital day #5. For reinfection, peak illness occurred in the 2nd hospitalization (July) on hospital day #1. ** Normal ranges given as indicated. † SARS-CoV-2 qualitative polymerase chain reaction (rt-PCR) cycle threshold (CT) was based on the WHO assay in March (UW Virology) and the Cepheid Infinity in July (LabCorp Seattle).